Cite
APA Citation
Chaloupka, F. J., Warner, K. E., Acemoğlu, D., Gruber, J., Laux, F., Max, W., Newhouse, J., Schelling, T., & Sindelar, J. (2015). an evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation. Tobacco control, 24(2), 112–119. http://access.bl.uk/ark:/81055/vdc_100135564050.0x000024